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Poking cells for efﬁcient vector-free
intracellular delivery
Ying Wang1, Yang Yang2, Li Yan2, So Ying Kwok2, Wei Li1, Zhigang Wang3, Xiaoyue Zhu2,
Guangyu Zhu3, Wenjun Zhang2, Xianfeng Chen2 & Peng Shi1,4
Techniques for introducing foreign molecules and materials into living cells are of great
value in cell biology research. A major barrier for intracellular delivery is to cross the cell
membrane. Here we demonstrate a novel platform utilizing diamond nanoneedle arrays to
facilitate efﬁcient vector-free cytosolic delivery. Using our technique, cellular membrane is
deformed by an array of nanoneedles with a force on the order of a few nanonewtons. We
show that this technique is applicable to deliver a broad range of molecules and materials
into different types of cells, including primary neurons in adherent culture. Especially,
for delivering plasmid DNAs into neurons, our technique produces at least eightfold
improvement (B45% versus B1–5%) in transfection efﬁciency with a dramatically shorter
experimental protocol, when compared with the commonly used lipofection approach. It is
anticipated that our technique will greatly beneﬁt basic research in cell biology and also a
wide variety of clinical applications.
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E
fﬁcient delivery of molecules and materials into living cells
is of great value to both basic study of cell biology and
the development of novel therapeutics1,2. For instance,
reprogramming somatic cells to induced pluripotent stem cell
state can be achieved by intracellular delivery of genes3, proteins4
or messenger RNA5 of speciﬁc transcriptional factors, which
holds the potential to revolutionize regenerative medicine by
creating patient-speciﬁc cell-based therapies. Numerous other
materials such as small interfering RNA6, peptides7 and
nanoparticles2 have also been explored for potential medical
applications, but successful intracellular delivery is essential for
them to be functional. However, cell membranes are mostly
impermeable to nuclide acid, proteins nanomaterials, and so on.
Many strategies have been developed to facilitate the cross-
membrane movement of these molecules. Each established
method has its own advantages and drawbacks regarding
different aspects of the delivery process, including efﬁciency,
expression level, toxicity and cell viability, and equipment
requirements. Viral vector based techniques are limited to
nuclide acid delivery, and the procedures are labour
intensive, often involving various safety issues8–10. Chemical
methods, such as lipofection, is relatively simple to perform,
but the efﬁciency for post-mitotic cells are typically very low
(B1–5% in neuron)11,12, and is not suitable for structurally
diverse materials (protein nanomaterials). Calcium phosphate
precipitation is a cost-effective method, but it is difﬁcult to yield
reproducible results and the transfection efﬁciency is also low13.
Electrical methods (for example, electroporation14 and
nucleofection15) temporarily alter the properties of cell
membranes by exposing them to voltage pulses to allow
charged materials to enter cells, but they typically require cells
in suspension and the toxicity can vary dramatically depending
on different cell types.
Recently, mechanical disruption to cell membranes is emerging
as a promising general alternative for cytosolic delivery16–20.
For example, single nanoneedle with a diameter of 800 nm or
below has been used for intracellular delivery without causing
serious damage to cells21, but this approach requires the use of
atomic force microscope (AFM), and the throughput is extremely
low. Even though arrays of carbon nanoﬁbers17 or
nanoneedles18,20 have been applied to improve the efﬁciency,
these methods either require cells to be cultured on nanostructure
substrates, which are chemically modiﬁed with cargo molecules
(for example, DNA), or can only be used with suspended cells,
and therefore, lack the versatility to work in many contexts.
Furthermore, the applicability of the nanoneedle-based technique
to hard-to-transfect cells, especially post-mitotic cells (for
example, neurons), still remains elusive.
Here, we show a novel platform utilizing diamond nanoneedle
arrays to facilitate efﬁcient vector-free intracellular delivery in
different types of cells, including primary neurons in adherent
culture. In this platform, cellular membrane is contacted and
deformed by an array of nanoneedles with a force on the order of
a few nanonewtons, which is precisely controlled by centrifuga-
tion-induced supergravity. We demonstrate that this technique is
applicable to deliver a broad range of molecules and materials,
including small chemicals, antibodies, quantum dots (QDs),
nanoparticles, and DNAs, in a high throughput manner.
Especially for delivering plasmid DNAs into neurons, our
technique produces at least eightfold improvement (B45%
versus B1–5%) in transfection efﬁciency with a dramatically
shorter experimental protocol, when compared with the com-
monly used lipofection approach.
Results
Delivery approach and its working principle. The principle and
work ﬂow of the nanoneedle array-based delivery system are
illustrated in Fig. 1. When a nanoneedle array is applied to cells
with controlled force, the nanoneedles temporarily deform the
Remove
medium
Spin and
penetration
Add 50 μL
solution
a b
Add 450 μL
solutionPlace
nanoneedles
After
30 mins
Replace
medium
Remove
nanoneedles
ε
Figure 1 | Schematic of the nanoneedle array-based intracellular delivery system. (a) Illustration of the basic design and working principle. (b) The work
ﬂow of the delivery procedures using nanoneedle arrays. The interaction between nanoneedles and cells was precisely controlled by centrifugation-induced
supergravity to achieve reliable and efﬁcient cytosolic delivery. Brieﬂy, the culture medium was ﬁrst removed, and replaced with basal medium
containing materials to be delivered (ﬂuorescent dye, dextran, antibody, nanoparticle, DNA, and so on). The solution volume was just enough to cover all
the cells and to prevent cells from drying. A nanoneedle array was then placed onto the solution with nanoneedles facing towards cells, leaving a thin layer
of solution between the nanoneedles and the cells. The whole setup was placed in a centrifuge and spun at various speeds. After centrifugation, extra
basal medium (containing cargo materials at desired concentrations) was immediately added to the culture well to lift off the nanoneedle patch.
After 5–30min incubation at 37 C, fresh culture medium was used to wash off extra materials and to culture the cells for further analysis. The nanoneedle
patch was then cleaned with piranha solution for reuse.
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cell membrane. Depending on the size and geometry of the
nanoneedles, the cell membrane can be induced to be accessible
to materials from the surrounding medium for a short period of
time, and foreign materials can therefore directly diffuse into cell
cytoplasm before the recovery of the membrane deformation. To
implement this approach, especially for but not limited to
adherent cultured cells, our nanoneedle array was gently placed
on top of cells with the needles facing towards cells. In order to
gently and precisely control the force applied to poke cells, the
whole setup was maintained in a supergravity environment by
centrifuging at optimized speeds. By changing the centrifugation
speed, the interaction force between nanoneedles and cell mem-
brane can be controlled accordingly. Unlike previous methods
using single nanoneedle to address individual cells with expensive
equipment like AFM22, our technique does not rely on any special
equipment and is very straightforward, while still providing
sufﬁcient control to achieve proper deformation of cell membrane
for intracellular delivery purpose (Supplementary Fig. 1).
Fabrication of nanoneedle array. We fabricated diamond
nanoneedle arrays as shown in Fig. 2. Diamond was speciﬁcally
chosen for its superior mechanical strength and inertness, which
render our nanoneedle arrays durability and biocompatibility.
The individual nanoneedle was measured at 326±110 nm in
diameter and 4.55±0.68 mm in height, with a density of
B6.6 104mm 2, which was equivalent to B6 nanoneedles in
a contacting area of 10 10 mm2 (roughly the contacting area of
one cell). The optimal parameters of the nanoneedles can vary for
distinct type of cells. In this study, different nanoneedle designs
and experimental parameters have been explored to improve the
delivery results. Speciﬁcally, nanoneedles with a diameter larger
than 800 nm caused signiﬁcantly more damage to cells than those
with diameters smaller than 400 nm. We also found that the
cylindrical nanoneedles with a vertical wall perform better and
more consistently than the cone-shaped nanoneedles with a
tapering wall (Supplementary Fig. 2, and Supplementary Note 1).
These results are consistent with a previous report by Obataya
et al.23, which suggested that a vertical sidewall is more suitable
for rapid penetration of cell membrane.
Cytosolic delivery. To validate our system, we ﬁrst used a live/
dead (calcein acetoxymethyl (calcein AM)/ethidium homodimer-
1 (EthD-1)) staining kit to characterize the delivery efﬁciency in
ﬁbroblast cells. This kit has been widely used to characterize cell
viability and cytotoxicity24. In our assays, with application of
nanoneedle array to cells, the membrane-permeant calcein AM
entered cells and was cleaved by esterases in live cells to yield
cytoplasmic green ﬂuorescence; while the membrane-impermeant
EthD-1 also entered treated cells and labelled their nucleic acids
(NAs) with red ﬂuorescence. The observation of both green and
red ﬂuorescence in treated cells indicated that successful cytosolic
delivery of molecules (EthD-1) was achieved without signiﬁcantly
injuring them (Fig. 3). In comparison, dead cells showed
only red ﬂuorescence without positive calcein AM staining
(Supplementary Fig. 3).
To optimize the force applied onto the cell membranes through
nanoneedles, the whole setup (cell culture plus nanoneedle array,
Fig. 1) was maintained in supergravity by centrifugation at a
series of speeds from 300 r.p.m. (12.8 g, RCF) to 1,000 r.p.m.
(142 g). As shown in Fig. 3b, when the centrifuging speed
increased from 300 to 500 r.p.m. (35.5 g), the cytosolic delivery
efﬁciency of EthD-1 improved signiﬁcantly from B5% at
300 r.p.m. to B80% when the speed was 500 r.p.m. or above,
without causing much increase in the number of dead cells
(Fig. 3c). The high delivery efﬁciency and cell viability were
further veriﬁed using a method combining FITC-labelled dextran
and propidium iodide to differentiate ‘liveþ delivered’ cells from
dead cells19. At a spinning speed of 500 r.p.m., both microscopy-
based analysis (Fig. 3 and Supplementary Fig. 4) and ﬂow
cytometry analysis (Supplementary Fig. 5) conﬁrmed delivery
efﬁciency above B60% for 3–5 kDa dextran molecules and cell
viability of around B95% in ﬁbroblast cells. Similar results
have also been achieved in another cancer cell line (A549,
Supplementary Fig. 6).
Application to primary neurons. Intracellular delivery into post-
mitotic cells, such as neuron, has always been challenging12,15. To
demonstrate our method’s potential as a promising universal
alternative for cytosolic delivery applications, we tested the
technique in primary hippocampal neurons. Compared with
ﬁbroblast cells, neurons were more vulnerable to membrane
deformation induced by nanoneedle arrays. Generally, a relatively
lower spinning speed was required to achieve similar delivery
efﬁciency as in ﬁbroblast cells (Fig. 4). The optimal centrifugation
speed was shown to be around 300 r.p.m. (lowest among tested
speeds, 12.8 g), at which a delivery efﬁciency of about 80% was
achieved for small molecules, EthD-1. Gradually raising the speed
to 700 r.p.m. signiﬁcantly increased the rate of dead cell to more
than 20%. Therefore, a centrifugation speed of 300–400 r.p.m. was
selected for following experiments with primary neurons. At this
speed, we also demonstrated highly efﬁcient cytosolic delivery of
dextran molecules in primary neurons with minor damage to the
cells (Fig. 4, and Supplementary Fig. 7).
Universal delivery method for various materials. In addition to
EthD-1 and dextran molecules, we further investigated whether
our method can facilitate cytosolic delivery of a wide range of
molecules and materials into primary neurons. As shown in
Fig. 5a, ﬂuorescently labelled antibody (donkey immunoglobulin
G) can be successfully delivered to cytoplasm of neuronal cells
using our technique with an efﬁciency of 35.5±4.4% (n¼ 3,
mean±s.e.m.). Neuron cells loaded with antibodies were still
viable 24 h after the delivery of antibodies (Supplementary Fig. 8).
We then demonstrated intracellular delivery of nanoparticles of
Figure 2 | Characterization of diamond nanoneedle array. (a) Overall view (scale bar, 10mm) and (b) detailed view (scale bar, 2 mm) of a nanoneedle
array by scanning electron microscopy.
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different sizes and properties. It was shown that QDs (20 nm in
diameter) could be rapidly delivered into more than 60% of
neurons in less than 30min after nanoneedle treatment (Fig. 5b).
The QDs were uniformly distributed across cytoplasm area and
were not conﬁned within lysosome structures (Fig. 5e,
Supplementary Fig. 9), suggesting that endocytosis did not play
major roles in the nanoneedle-facilitated delivery25,26. The fast
delivery dynamics was also observed for large polystyrene
nanoparticles (200 nm in diameter, Fig. 5c). A three-
dimensional reconstruction of the Z-series scanning conﬁrmed
that the delivered nanoparticles were actually inside the cells
(Fig. 5f), and 14.8±2.9% (n¼ 3, mean±s.e.m.) of the cells were
successfully loaded with these beads. In our control experiments,
where the neuron cells were exposed to the nanomaterials (QDs
and polystyrene particles) without being treated with the
nanoneedles, only minimum ﬂuorescent signal was observed
(Fig. 5d).
The delivery of NAs into cells is crucial for the study of many
aspects of neurobiology. Therefore, we then investigated the
ability of our system to facilitate the delivery of plasmid DNAs
into neuronal cells. Protein expression from plasmid DNAs
requires the transport of DNAs into cell nucleus. The commonly
used lipofection technique usually gives poor results in post-
mitotic cells in terms of transfection efﬁciency (1–5% in primary
neuron)12. Also, the protocol is typically time consuming (several
hours) due to the endocytosis-based internalization of DNA–lipid
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Figure 3 | Centrifugation controlled intracellular delivery in ﬁbroblast cells. (a) Calcein AM) ﬂuorescence image of live ﬁbroblast cells after
nanoneedle treatment. (b) EthD-1 ﬂuorescence image of successfully delivered cells. (c) Merged image combining calcein AM and EthD-1 channels.
(d) Bright-ﬁeld (BF) image of the cells. Scale bar, 100 mm. (e) Quantiﬁcation of delivery efﬁciency at various centrifugation speeds. (f) Quantiﬁcation of cell
viability after delivery using nanoneedle arrays. (g) Fluorescence image of cells delivered with FITC-labelled dextran. (h) Propidium iodide (PI) ﬂuore-
scence image of dead cells 18 h after delivery. (i) Merged image combining dextran and PI channels. (j) Bright-ﬁeld image of the cells. Scale bar, 100mm.
(k) Quantiﬁcation of dextran delivery efﬁciency and dead cell rate in ﬁbroblasts using nanoneedle arrays at 500 r.p.m. For e,f,k, error bars indicate
s.e.m. from three independent experiments.
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complexes. In our method, the plasmid DNAs were ﬁrst
complexed with lipid molecules, and were then delivered into
cells with nanoneedle treatment followed by incubation for a
short period of time (5–30min). The lipid molecules, in this case,
helped protect DNAs from degradation27 and facilitated their
transport from cytoplasm into nucleus. As shown in Fig. 6, a
transfection rate of around B45% in primary neurons (6–7 days
in vitro, DIV) was consistently achieved with our technique. The
delivery and subsequent transfection was quite uniform across the
whole area covered by nanoneedle patches, as indicated by a
panoramic view stitched from multiple images of treated samples
(Fig. 6b). Compared with traditional lipofection in primary
neuron, our nanoneedle array-based technique signiﬁcantly
increased the transfection efﬁciency by almost eightfolds, with a
dramatically shorter (10–30min versus a few hours) experimental
protocol without using any special equipment (Fig. 6f, and
Supplementary Fig. 10). Importantly, we introduced a
centrifugation-based method to achieve precise control of the
force applied through nanoneedles to deform cell membrane.
This simple but effective delivery process was gentle enough to
ensure cell viability, even in delicate post-mitotic neurons, as
indicated by different viability assays (Supplementary Fig. 11) and
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Figure 4 | Intracellular delivery in hippocampal neurons. (a) Calcein AM ﬂuorescence image of live neuron cells after nanoneedle treatment.
(b) EthD-1 ﬂuorescence image of successfully delivered cells. (c) Merged image combining calcein AM and EthD-1 channels. (d) Bright-ﬁeld image of the
neuron cells (6–7 DIV). Scale bar, 100 mm. (e) Quantiﬁcation of delivery efﬁciency at various centrifugation speeds in neurons. (f) Quantiﬁcation of
neuron viability after delivery using nanoneedle arrays. (g) Fluorescence image of neurons delivered with FITC-labelled dextran. (h) Propidium iodide (PI)
ﬂuorescence image of dead cells 18 h after delivery. (i) Merged image combining dextran and PI channels. (j) Phase-contrast (ph) image of the neuron cells.
Scale bar, 100mm. (k) Quantiﬁcation of dextran delivery efﬁciency and dead cell rate in neurons using nanoneedle arrays at 400 r.p.m. For e,f,k, error bars
indicate s.e.m. from three independent experiments.
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immunostaining of critical neuronal markers (MAP2 and
40,6-diamidino-2-phenylindole) in green ﬂuorescent protein
(GFP)-transfected cells (Supplementary Fig. 12). Moreover, the
nanoneedle-treated neuronal cells can be further maintained in
long-term culture with proper cellular development and stable
expression of GFP, and formed functional synapses as
indicated by the staining of vesicular glutamate transporter 1
(vGlut1, Fig. 7).
Discussion
In this study, we demonstrated a novel technology for efﬁcient
vector-free intracellular delivery. In this method, a diamond
nanoneedle array is used to temporarily deform the cell
membrane in a well-controlled manner to facilitate reliable
intracellular delivery. This technique is applicable to different
types of adherent cells, including primary neurons, which are post
mitotic and usually difﬁcult to treat with traditional methods12,15.
Our approach is suitable for delivery of a wide range of molecules
and materials, including small chemicals, antibodies, QDs,
nanoparticles, NAs and so on. These results demonstrated the
powerful capability of our system as a universal alternative for
intracellular delivery. Unlike many current methods such as cell
penetrating peptide or nanomaterials based techniques, this
method is independent of molecular structure, particle size
(below the diameter of nanoneedles) and surface chemistry,
which renders signiﬁcant freedom in designing novel intracellular
sensors based on different molecules and materials, and greatly
expands the ability to study cell signalling processes with these
novel probes. Notably, the versatility of our nanoneedle array-
based technology was further reﬂected by its capability to work
with neuron cells in different contexts. For example, QDs could
be successfully delivered at various concentrations in the working
solution (1.6 nM, 8 nM and 40 nM), which accordingly resulted in
different intracellular concentrations of QDs in delivered cells
(Supplementary Fig. 13), suggesting that concentration of cargo
materials is not critical for the successful delivery using our
method. In addition, both QDs and DNA plasmids have been
successfully delivered into neurons of different stages, ranging
from young (2–3 DIV) to old (12–13 DIV) cultures (Fig. 8,
Supplementary Fig. 14), providing the ﬂexibility to perform
genetic manipulation of neurons at different stages to
accommodate various neurobiology studies.
Similar to nucleofection15 and microinjection28, our technique
is largely based on a membrane deformation mechanism, by
which exogenous materials in medium can freely diffuse into cell
0
1
2
3
4
0 10 20 30
Distance (μm)
Antibody
0
5
10
15
20
25
QDs NPs
Fl
uo
re
sc
en
ce
 (a
.u.
) *
* *
An
tib
od
y
Fluorescent
QD
s
N
an
op
ar
tic
le
s
PH
Fl
uo
re
sc
en
ce
 (a
.u.
)
Cell top
Cell base z
y x
Nanoneedle versus endocytosis
Figure 5 | Delivery of various molecules and materials into neurons. (a) Bright-ﬁeld and ﬂuorescent images of neurons loaded with antibodies, donkey
IgG labelled with Alexa Fluor 647. (b) Bright-ﬁeld and ﬂuorescent images of neurons loaded with QDs, 625 nm emission wavelength. (c) Bright-ﬁeld and
ﬂuorescent images of neurons loaded with 200nm polystyrene nanoparticles, scale bar, 20mm. (d) Comparison of the delivery efﬁciencies of the
nanoneedle array-based technique and endocytosis-based internalization of different materials. Error bars indicate s.e.m. of the sample, n420 for each
condition, *Po0.01 determined by Kruskal–Wallis test. (e) Distribution of QD ﬂuorescence signal in a neuron across the spatial extent indicated
by the dashed line in b. (f) A cross-sectional image of a three-dimensional reconstructed cell from Z-series ﬂuorescent images of the boxed cell in c, the
sectioning plane is indicated by the dashed line in c.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5466
6 NATURE COMMUNICATIONS | 5:4466 | DOI: 10.1038/ncomms5466 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
cytosol through deformed membrane after nanoneedle treatment.
Treating cells with simple centrifugation or ﬂat diamond ﬁlm-
coated patches could not achieve any intracellular delivery
(Supplementary Fig. 15), thus highlighting the importance of
the nanoneedle structures. The advantages of our technique are
obvious (Supplementary Table 1): no electrical ﬁeld or any special
device is needed, and therefore, the most sensitive cargo
materials, such as biologic molecules and QDs, can be delivered
intact without being affected by electrical ﬁeld. Meanwhile, we
demonstrated very high cell viability (B90%) in ﬁbroblast, cancer
cell line and neuronal cells, which is achieved by simple, gentle
and reliable control of the interaction between nanoneedles and
the cells with centrifugation-induced supergravity. By our
estimation, the force applied on cells through single nanoneedle
is around 2 nN (Supplementary Fig. 16), given a centrifugation
speed around 300 r.p.m. (12.8 g). This is on the same order as
previously reported value, regarding the magnitude of force
required to penetrate cell membranes22. Such precise control was
achieved without using any special equipment, and guaranteed
consistent deformation of cell membrane for reliable intracellular
delivery. In contrast to previous studies where AFM with single
nanoneedle tip was used to poke cells with very delicate
manipulations22,29,30, our system’s ease-of-use and high
throughput capability give the potential to be easily adopted in
other laboratories.
Moreover, our results showed that signiﬁcant delivery of GFP
plasmid (B20%) already happened with just 5-min incubation of
lipid DNA particles with treated cells (Fig. 6f), indicating that the
relatively slow endocytotic pathway31 is not essential for
nanoneedle-facilitated delivery. Also, performing the delivery
experiments at 4 C, at which endocytosis is minimized32, did not
signiﬁcantly reduce the delivery efﬁciency (Supplementary
Fig. 14). This is consistent with a recent report showing that
diffusion plays major roles for the intracellular delivery through
cell membrane disrupted by mechanical restriction19. However,
our current results cannot exclusively rule out the possibility that
cellular endocytosis may undergo certain changes in dynamics as
a result of nanoneedle treatment and contribute to the enhanced
cytosolic delivery in our system. Interestingly for DNA delivery,
even though the nanoneedle induced membrane deformation
(B300–400 nm) is probably adequate for DNA plasmid to pass
through, the transfection rate was extremely low (o1%) in
neurons delivered with bare plasmid DNAs (not complexed with
lipofectamine), similar result (B3%) was also observed in the
A549 cancer cell line (Supplementary Fig. 17), suggesting that
simple cytoplasmic delivery of bare DNAs is not sufﬁcient for
their successful translocation into nucleus and subsequent
expression. This could potentially attribute to two issues. First,
it is probably difﬁcult to simultaneously treat both cell membrane
and nucleus membrane by nanoneedle arrays for cargo molecules
and materials to be delivered into cell nucleus. Second, the
delivered DNAs may undergo fast degradation in cytoplasm and
fail to reach the nucleus. A previous report by Shimizu et al.27
showed that the diffusion of extrachromosomal DNA in
cytoplasm is dramatically limited by structure proteins; and is
being eliminated by cells rapidly. Therefore in our system, a
second mechanism was engaged to facilitate DNA transport from
cytosol to nucleus by complexing and protecting DNAs with
lipid-based materials, which could also help package DNA into a
smaller hydrodynamic radius, thus enabling more rapid diffusion
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Figure 7 | Long-term culture of nanoneedle-treated neuron cells. After
delivery of GFP plasmid using the nanoneedle-based technique, the neuron
cells were ﬁxed at 14 DIV (1 week after transfection) and were immuno-
stained for (a) GFP, (b) MAP2 and (c) vGlut1. (d) Merged image combining
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into the cytoplasm. Such combination signiﬁcantly (B8 folds)
improved the transfection efﬁciency in post-mitotic neurons
with a dramatically shortened experimental protocol, compared
with traditional lipofection technology. The reduction of
incubation time (for cells and DNA–lipid complexes, Fig. 6f)
not only minimized the cytotoxicity of lipid chemicals at
high concentrations, but also dramatically increased the
turnover and throughput of cellular assays involving gene
manipulations. In the future, the design and fabrication of our
nanoneedle arrays can be further improved to facilitate direct
delivery of materials into cell nucleus. We believe that the efﬁcacy
and convenience of this technique will render it great potential to
be adopted in many avenues of biological research and clinical
applications.
Methods
Nanoneedle array fabrication. The fabrication is based on two processes:
deposition of nanodiamond ﬁlm and subsequent bias-assisted reactive ion etching
(RIE) by electron cyclotron resonance microwave plasma chemical vapour
deposition (MPCVD). N-type (001) silicon wafers of 3 inches in diameter were
used as substrate. Before nanodiamond deposition, the substrate was ultrasonically
abraded for 60min in a suspension of nanodiamond powders with a grain size of
5 nm in ethanol. Nanodiamond ﬁlms of 7 mm thick were deposited in step one
using a commercial ASTeX MPCVD equipped with a 1.5 kW microwave generator.
The nanodiamond deposition was performed in the plasma induced in a 10% CH4/
H2 mixture at a total pressure of 30 torr and total gas ﬂow rate of 200 sccm. The
microwave power and deposition temperature were maintained at 1,200W and
800 C, respectively. After ﬁnishing the nanodiamond ﬁlm deposition, the second
step of RIE was performed using electron cyclotron resonance MPCVD. The
ASTeX microwave source employed a magnetic ﬁeld of B875 Gauss generated by
an external magnetic coil. The RIE conditions were as follows: H2 was used as the
reactive gases at a total ﬂow rate of 20 sccm; the substrate bias was  200V; the
reactant pressure 7 10 3 torr. The etching duration was 3 h and the input
microwave power 800W, respectively. The morphology of diamond nanoneedle
patch was characterized by a Philips FEG SEM XL30. The sample was tilted 90 for
scanning electron microscopy.
Cell cultures. NIH3T3 ﬁbroblast cells (ATCC) were maintained in Dulbecco’s
modiﬁed Eagle medium (DMEM, Life Technology) supplemented with 10% fetal
bovine serum Hyclone, L-glutamine and penicillin/streptomycin.
All procedures involving animals were approved by the animal ethical
committee of City University of Hong Kong. Hippocampal neuron cultures were
prepared following the method previously described33. Brieﬂy, dissociated neurons
were prepared from hippocampi dissected from E18 Sprague–Dawley rats by
enzymatic treatment with papain (Sigma) for 30min at 37 C followed by
triturating with a 1ml pipette tip. Before seeding neurons, all substrates were
precoated with polylysine (Sigma, 100 mgml 1) and laminin (Invitrogen,
10 mgml 1). Further details of cell culture and analysis can be found in the
Supplementary Methods.
Delivery procedure. Culture medium was replaced by working medium con-
taining various materials (EthD-1, dextran, antibody, nanoparticle, DNA, and so
on). A nanoneedle array patch was then placed to ﬂoat on culture medium with the
needles facing towards cells, leaving a thin layer of solution between nanoneedles
and cell membrane. The whole setup was centrifuged at various speeds. After
centrifugation, more medium was immediately added to the culture well, lifting off
the nanoneedle array patch. After 5–30min, fresh medium was used to wash off
extra cargo materials. The chips with nanoneedle array were cleaned with piranha
solution for 1 h before reuse.
For intracellular delivery of small molecules (EthD-1, Life Technology), dextran
(3–5 kDa, Sigma), antibodies (Alexa Fluor 647 labelled Donkey IgG, Life
Technology), QDs (625 nm emission wavelength, Wuhan Jiayuan) and polystyrene
beads (200 nm, Wuhan Jiayuan), cells were incubated with these materials for
30min before medium replacement to wash out extra materials. Examination of
delivery status was performed by ﬂuorescent imaging after culturing the cells for
certain period. To deliver GFP plasmid DNAs, the DNAs were ﬁrst complexed with
Lipofectamine 2000 (Life Technology) for 10–15min, and applied to treated cells
for 5–30min. Cells were then cultured overnight before imaging of GFP expression.
Further details of the cell delivery procedure can be found in the Supplementary
Methods.
Immunocytochemistry. For immunostaining, cells were ﬁxed for 15min in 4%
paraformaldehyde in phosphate-buffered saline (PBS), permeablized in 0.25%
Triton X-100 for 10min and then blocked with 4% bovine serum albumin in PBS
for 2 h at room temperature or overnight at 4 C. Cultures were incubated with
primary antibodies in 4% bovine serum albumin for 2 h at room temperature,
rinsed with PBS, incubated with secondary antibodies for 1 h and were again rinsed
with PBS. In some cases, cell nuclei were stained with 40 ,6-diamidino-2-pheny-
lindole before imaging. The primary antibodies included mouse anti-GFP (Milli-
pore, 1:1,000), rabbit anti-MAP2 (Millipore, 1:1,000), and mouse anti-vGlut1
(Millipore, 1:500).
Image acquisition and analysis. Samples were imaged on an Olympus IX81
microscope equipped with a motorized stage, cooled sCMOS camera and a  10
objective (NA 0.4), a  20 objective (NA 0.7) and a  60 oil immersion objective
(NA 1.2). Images were taken using Micromanager and analysed with ImageJ.
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Supplementary Figures 
 
 
 
Supplementary Figure 1. Nanoneedle configuration in cell membrane examined by confocal 
laser scanning microscopy. a) 3D reconstruction of a cell with its membrane fluorescently labeled 
by CellMask staining (red), and the nanoneedles were fluorescently labeled with Alexa Fluor 488 
(green). b) A cross-sectional (x-z) plane of the cell showing membrane disruption induced by the 
diamond nanoneedles. 
 
 
 
 
 
Supplementary Figure 2. Various configuration of diamond nanoneedles used in the 
optimization process.  a) Nanoneedles of
  ~
1µm diameter. b) The cone-shaped and cylindrical 
nanoneedles used to disrupt cell membranes.   
 Supplementary Figure 3. Without nanoneedle facilitated intracellular delivery, EthD-1 is not 
able to cross the cell membrane, and only the dead cells were labeled with red fluorescence. a) 
fibroblast cells, b) Neuronal cells (4DIV). Scale bar, 100 µm. 
 Supplementary Figure 4.  Delivery of dextran in fibroblast cells. a) Stitched phase-contrast 
image of a fibroblast culture treated by a nanoneedle patch. b) Stitched fluorescence images of 
cells delivered with FITC-labeled dextran. In panel (a) and (b), red squares indicate the area 
covered by the nanoneedle patch, scale bar, 1.6 mm. c), d) Enlarged view of the yellow line 
boxed regions in panel (a) and (b), respectively. e) Propidium iodine (PI) staining of the cells 
shown in panel (c) and (d), PI was added to cells right before imaging to label dead cells. Scale 
bar, 200 µm. 
 Supplementary Figure 5. Flow cytometry analysis of dextran delivery into fibroblast cells using 
nanoneedle array based technique. Analysis was done 18 hours after nanoneedle treatment, and PI 
was added to cells right before flow cytometry analysis to label dead cells. 
 
 
  
Supplementary Figure 6.  Delivery of dextran in A549 cancer cells. a) Stitched phase-contrast 
image of an A549 culture treated by a nanoneedle patch. b) Stitched fluorescent images of cells 
delivered with FITC-labeled dextran. In panel (a) and (b), red squares indicate the area covered 
by the nanoneedle patch. Scale bar, 1.6 mm. c), d) Enlarged view of the yellow line boxed regions 
in panel (a) and (b), respectively. e) Propidium iodine (PI) staining of the cells shown in panel (c) 
and (d), scale bar, 200 µm. f) Quantification of dextran delivery efficiency and cell viability in 
A549 cells using nanoneedle arrays. Error bars indicate s.e.m. from three independent 
experiments. 
 
 
Supplementary Figure 7.  Delivery of dextran in neuronal cells. a) Stitched phase-contrast 
image of a neuronal culture (6-7DIV) treated by a nanoneedle patch. b) Stitched fluorescent 
images of PI staining.  c) Stitched fluorescent images of neurons delivered with FITC-labeled 
dextran. Scale bar, 1.6mm. d), e) & f) Enlarged view of the boxed regions (yellow line) in panel 
(a), (b) and (c), respectively. Scale bar, 100 µm. 
  
 
 
 
Supplementary Figure 8. Evaluation of neuron viability by PI staining at 24h after delivery of 
antibodies.  a) Fluorescence image showing successful delivery of pre-labeled IgG into neurons at 
6-7DIV. b) Fluorescence image of PI staining. Scale bar, 100 µm. c) Phase-contrast image of 
treated neurons. d) Merged images combining different channels. Arrows in the panel a) and b) 
indicate representative antibody-loaded cells with intact phase halo. 
 
  
Supplementary Figure 9. High-resolution (60x) DIC (a) and fluorescence (b) images of neuron 
cell (6-7DIV)  loaded with quantum dots (QDs), showing a uniform distribution of QDs in cell 
cytoplasm. Scale bar, 20 µm. (c) Bright-field (bf) image and fluorescent staining of lysosome 
(lyso) in fibroblast cells loaded with QDs using nanoneedle treatment. Scale bar, 10 µm.  
 
 
Supplementary Figure 10. Traditional lipofection in primary neuron cells (6DIV). a) Bright-
filed image, b) GFP fluorescence image, c) Merged image of a neuron culture transfected with 
GFP plasmid using lipofectamine 2000. Scale bar, 100 µm. Neurons were incubated with 
DNA:lipid complexes for 2 hours before replacing the medium. The transfection efficiency is 
below 5%. 
  
 
 
Supplementary Figure 11. Evaluation of neuron viability by PI staining after delivery of GFP 
plasmid DNAs using nanoneedle based technique. a) GFP fluorescence image showing successful 
delivery of DNA plasmid into neurons at 6-7DIV. b) Fluorescence image of PI showing dead cells 
after delivery. Scale bar, 50 µm. c) Merged images combining GFP and PI channels. d) Phase-
contrast image of treated neurons.  
  
 
 
Supplementary Figure 12. High-resolution (60x) images of neuron cells (7DIV) one day after 
delivery of GFP plasmid using nanoneedle based technique.  a) Fluorescence image of MAP2 
staining. b) Fluorescence image of GFP staining. c) Fluorescence image of DAPI staining. d) 
Differential interference contrast (DIC) image of the cells. e) Merged image combining GFP 
(green), MAP2 (red) and DAPI (blue) channels. Scale bar, 20 µm. 
 
 
 
 
Supplementary Figure 13. Delivery into hippocampal neurons (6-7DIV)  using different 
concentrations of QDs: a) 1.6 nM; b) 8 nM; c) 40 nM. Scale bar, 100 µm. d) Quantification of 
intracellular concentration of QDs under various working (extracellular) concentrations, as 
indicated by the normalized cytosolic fluorescence, error bars indicate s.d. from at least 50 
sampled cells.  
 
 
 
Supplementary Figure 14. Delivery of QDs in cultured primary neurons of different stages. a), 
b), c) and d) Fluorescence images showing successful delivery of QDs into neurons of 2-3DIV, 6-
7DIV, 9-10DIV, and 12-13DIV, respectively. e), f), g) and h) Merged images combining 
fluorescence (panel (a), (b), (c) & (d)) and bright-field (or phase-contrast) images showing the 
status of neuron cultures. Scale bar, 100 µm. i) Quantification of delivery efficiency in neurons at 
different stages using the nanoneedle based technique, error bars indicate s.e.m from three 
independent experiments. j) Delivery QDs into neurons at 4 ºC, error bars indicate s.e.m from 
three independent experiments. 
*
P>0.05, 
**
P<0.001 determined by ANOVA analysis. 
  
 
 
 
Supplementary Figure 15.    Control experiments of intracellular delivery of EthD-1/Calcein 
AM (C-AM) or dextran/ propidium iodide (PI) using diamond-film-coated patches in a) neuron 
cells (6-7DIV) b) fibroblast cells. Scale bar, 100 µm.  
  
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 16. a) Analysis of the force on individual nanoneedles when they are in 
contact with cell membrane under centrifugation. ρsi is density of silicon, L is the length of a 
square nanoneedle patch, H is the thickness of the nanoneedle patch, n is the total number 
nanoneedles on a patch, r is the length of spinning arm, ω is the spinning speed. b) The 
relationship between centrifugation speed (rpm) and Force on individual nanoneedles. 
 
 
  
Supplementary Figure 17. Delivery of GFP plasmid DNA into cells with nanoneedle treatment 
alone, without lipofectamine. a-c) Delivery of GFP plasmid into primary neurons (6-7DIV) with 
nanoneedle treatment alone. d-f) Delivery of GFP plasmid into A549 cells with nanoneedle 
treatment alone. Scale bar, 200 µm. 
  
Supplementary Tables 
 
Supplementary Table 1. Comparison of various delivery tehniques. 
Technique Advantages Drawbacks Ref 
Virus-based 
transfection  
(a) High-efficacy 
(b) Low cell toxicity 
(a) Safety concern 
(b) Laborious packaging required 
(c) Limited to nucleic acid  
(d) High-cost 
1 
Lipid based (a) Easy to use 
(b) High efficacy 
(c) Non-virus vector 
(a) Toxicity to cells 
(b) Dramatic cell morphology change 
(c) Low efficiency in post-mitotic cells 
2-3 
Ca2+ phosphate co-
precipitate 
(a) Easy to use 
(b) Cost-effective 
(c) Non-virus vector 
(a) Low efficiency 
(b) Time consuming protocol 
(c) Difficult to yield reproducible results 
4 
Biolistics (a) Quick and straightforward 
protocol  
(b) Applicable to tissue slices 
(a) Expensive equipment and reagent 
(b) Significant cell death 
5 
Microinjection (a) Introduction of wide range 
of molecules and materials 
(b) Direct nucleus injection 
(c) Selective transfection of 
specific cells 
(a) Expensive and special equipment 
(b) Extremely low throughput  
(c) Cell damage 
6-7 
Electroporation (a) Medium to high efficiency 
(b) Simple and quick protocol  
(a) Relatively expensive equipment and 
reagents 
(b) Can only be used for cells in suspension 
(c) Cell damage caused by long voltage pulse 
7-8 
Nucleofection (a) High-efficiency 
(b) Nuclear localization of 
transfected DNA 
(c) Easy and reproducible 
(a) Expensive equipment and reagents 
(b) Can only be used for cells in suspension 
(c) Require proprietary nucleofection solution 
(d) Program optimization may be required 
9 
Diamond nanoneedle 
array/ centrifugation 
controlled  
(a) Quick and straightforward 
protocol 
(b) High efficiency, even in 
post-mitotic cells 
(c) Applicable to wide range 
of molecules and materials 
(d) Cost effective, no special 
equipment required 
(a) Optimization may be required for different 
cell types 
 
 
  
Supplementary Notes 
 
Supplementary Note 1. Optimization of nanoneedles 
Throughout this study, we used different designs and experimental parameters to improve the 
delivery results. Although the process may be further optimized, we used the following 
experimental findings as a general guideline in designing the delivery protocol using nanoneedle 
patches. 
Diameter of nanoneedles. Cell viability is very sensitive to this parameter. Nanoneedles with a 
large diameter (e.g. 1 µm, Supplementary Figure 2a) caused significantly more dead cells than 
needles smaller than 400 nm. This is consistent with a previous report by Han et al (Biochem. 
Biophys. Res.Commun. 2005), which showed that nanoneedles larger than 800 nm in diameter 
cause significantly more damage to cells. Therefore, all the nanoneedles used in this study were 
designed to be less than 400 nm in diameter.  
Shape of nanoneedles. The shape of nanoneedles can also affect the delivery efficiency. As 
shown in Supplementary Figure 2b, we found that the cylindrical nanoneedles with a vertical 
wall perform better and more consistently than the cone-shaped nanoneedles with a tapering wall, 
even though these two designs can ideally make similar sizes of membrane disruption with 
~
2 µm 
penetration depth.   
Density of nanoneedles.    To determine a suitable density of nanoneedles, we tested various 
densities ranging from 1x10
6
/cm
2
 to 15x10
6
/cm
2
.  Generally, the delivery efficiency increases as 
the needle density increases. However, too high densities (>10x10
6
/cm
2
) could also lead to 
dramatic decrease of delivery efficiencies. Therefore, we selected a density of 
~
6x10
6
/cm
2
, which 
was high enough to ensure 
~
6 nanoneedles in an area of 10 x10 µm
2
 (roughly the contacting area 
with one cell). 
Centrifugation parameters. Even though the centrifugation speed was the determinant factor to 
control the interaction between nanoneedles and cells, we found that the ramping speed was also 
important for the gentle and smooth application of nanoneedle arrays to cells, especially during 
the acceleration process. High ramping speed (e.g. 9 rpm/s) could cause movement of a patch on 
the cell layer, resulting scratched dead cells. So we selected ramping speeds of 3 rpm/s and 6 
rpm/s during the acceleration and deceleration process.  
 
 
 
 
 
 
 
Supplementary Methods 
 
Cell culture. NIH 3T3 fibroblast cells and A549 cancer cells were maintained in Dulbecco’s 
modified eagle medium (DMEM, Life Technology) supplemented with 10% fetal bovine serum 
(FBS, HyClone), L-glutamine and penicillin/streptomycin. Before any delivery experiments, cells 
were seeded in 4-well multidish (Nunclon, Thermo Scientific). 
For primary neuron culture, hippocampal neurons were cultured on 12 mm Germen coverslips 
(Bellco Glass). Before using, the coverslips were cleaned with concentrated nitric acid (70% 
wt/wt) overnight and rinsed with sterile DI water. The coverslips were further coated with 
polylysine (Sigma) at 100 μg/ml overnight and then laminin at 10 μg/ml (Invitrogen) for 4 hours 
before seeding neuron cells. Hippocampi tissue were dissected from E18 Sprague Dawley rats, 
and treated with papain (Sigma) for 30 min at 37 °C. Dissociated neurons were prepared by 
triturating enzymatic treated tissue with a 1 ml pipette tip in DMEM solution contain 10% FBS. 
Neurons were then seeded onto coated coverslips at a density of 3-5x10
4
/cm
2
 in 4-well 
multidishes. After the initial adhesion of neuron cells (2 hours after seeding), the medium was 
replaced by Neurobasal medium supplemented with B27, L-glutamine and 
penicillin/streptomycin. Half of the medium was replaced with fresh medium every 3-4 days. 
Delivery procedure. To perform cytosolic delivery into adherent cultured cells (in 4-well 
multidishes, 15mm diameter), the medium was firstly removed, and replaced with 50 µl basal 
medium (Neurobasal for Neuron, DMEM for other cells) containing materials to be delivered 
(fluorescent dye, dextran, antibody, nanoparticle, DNA, etc.). A patch with nanoneedle arrays 
was then placed onto the solution with nanoneedles facing toward cells, leaving a thin layer of 
solution between the nanoneedles and the cells. The whole setup was placed in a centrifuge 
(Sorvall ST 16R, Thermo Scientific) with a plate rotor (M-20 microplate swinging bucket rotor, 
Thermo Scientific) and spun at various speeds. To ensure a gentle poking process, the 
centrifugation was ramped at an acceleration rate of 3 rpm/s. The centrifugation was hold at 
desired spinning speed for 30 seconds before de-accelerate at 6 rpm/s. After centrifugation, 450 
µl basal medium (containing cargo materials at desired concentrations) was immediately added to 
the culture well to lift off the nanoneedle patches. After 5-30 minute incubation at 37 
ᵒ
C, fresh 
medium (with supplements) was used to wash off extra materials and to culture the cells for 
further analysis. The nanoneedles patches were then cleaned with piranha solution for one hour 
before reuse. 
Delivery materials. For intracellular delivery of various materials, the experiments were 
conducted as described above, and the delivery buffer contained various materials: Calcein-AM 
(1 µM) and EthD-1 (1 µM); or 0.5 mg/ml FITC-labeled dextran (3k-5kDa, Sigma); or 4x10
-5
% 
(w/v) polystyrene beads (200 nm, Wuhan Jiayuan); or 1 µg/ml antibodies (Donkey IgG, Life 
Technology) respectively. For delivery of QDs (Wuhan Jiayuan), different concentrations 
including 1.6 nM, 8nM and 40 nM were tested in neuron cells. The water soluble QD has a 
CdSe/ZnS based core/shell structure with a 625 nm emission wavelength, and were modified with 
a layer of polyethylene glycol (PEG). To deliver GFP plasmid DNAs, 0.5 µg DNAs were used for 
each well (15 mm diameter). The DNAs were firstly complexed with 0.5 µl lipofectamine 2000 
(Life Technology) in basal medium for 10-15 minutes, and then applied to cells for further 
treatment.  
Evaluation of delivery efficiency using live/dead staining. Unlike its common usage, the 
live/dead staining kit (Calcein AM/EthD-1, Life Technology) was used in a different way in this 
study to indicate that nanoneedles can mechanically disrupt cell membranes to allow EthD-1 
entering cells without affecting cell viability (stained by Calcein AM). Calcein AM (C-AM) is 
membrane-permeant and can be cleaved by esterases in live cells after entering to yield cytoplasmic 
green fluorescence, and it was used to label live cells after nanoneedle treatment. The membrane-
impermeant ethidium homodimer-1 (EthD-1) is commonly used to label dead cells with compromised 
cell membrane. In our experiments, cell membranes were temporarily disrupted by the nanoneedles, 
so EthD-1 could enter the cells before the recovery of cell membranes, and the cell viability remained 
unaffected. Therefore, the cells can be labeled as one of the following three conditions after 
nanoneedle treatment in the presence of C-AM/EthD-1: 1) C-AM
+
/EthD-1
+ 
, green/red (living cells 
being successfully delivered with EthD-1); or 2) C-AM
+
/EthD-1
-
 , green only (living cells but no 
delivery);  or 3)C-AM
-
/EthD-1
+
, red only (dead cells with corrupted cell membrane). By counting the 
percentage of cells in each condition, we were able to preliminarily analyze the performance of 
the nanoneedle based delivery technology. 
Flow cytometry. For flow cytometry analysis, 3T3 fibroblast cells were initially seeded in a 4-
well dish with a silicone mask, which was removed before nanoneedle treatment to make sure all 
cells being covered by the nanoneedle patches. Before analysis (18 hours after nanoneedle 
treatment), cells were washed two to three times with PBS, then treated with trypsin-EDTA (Life 
Technology) for 5 minutes and resuspended in PBS supplemented with 3% FBS, 1% F-127 
Pluronics, and 1-2 µg/mL propidium iodide (Sigma). Cells were analyzed on a FACSCalibur (BD 
Biosciences). Data analysis was conducted using FlowJo (Tree Star). 
Labeling nanoneedle array. The nanoneedle patches were thoroughly cleaned in methanol, 
acetone and methanol, each for 5 min; then rinsed with 2-propanol and water. The patches were 
further immersed in hot (~90 °C) piranha solution (3:1, v/v, 98% H2SO4 : 27.5% H2O2) for 
approximately 90 minutes, followed by sequential rinse with water, methanol, methanol/toluene 
(1:1), toluene, and dried with nitrogen. The cleaned nanoneedle patches were then immersed 3-
aminopropyl-triethoxysilane (APTES) solution (20% in toluene) under nitrogen overnight. 
Afterwards, the organosilane-coated nanoneedle patches were taken out from the deposition 
environment and residual coating material were removed by rinsing with ethanol, 2-propanol, and 
water and dried with nitrogen. 
Confocal Microscopy. Confocal laser scanning microscopy (SP8 TCS, Leica-Microsystems) was 
performed to verify the configuration of nanoneedles when they were in contact cell membrane. 
Before nanoneedle treatment, fibroblast cells were soaked with CellMask Orange Plasma stain 
(Life Technology) at a concentration of 5 µg/ml for 5 minutes, and then treated with nanoneedles 
as described above. Confocal microscopy was then performed before releasing of nanoneedles 
with a 40x water immersion objective (1.1 NA).   
Force evaluation. The force applied through individual nanoneedles was evaluated as illustrated 
in Supplementary Figure 18. Specifically, a square nanoneedle patch was given the following 
parameters: length L = 5 mm, thickness H = 500 µm, nanoneedle density N = 6.6x10
4
/cm
2
. For 
easy calculation purpose, the mass of the nanoneedle patch was approximately equivalent to the 
silicon part (diamond film was ignored). Under a balanced condition, the force (F) exerted 
through individual nanoneedle can be determined as:  
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Where ρsi is density of silicon (2.33x10
3
 kg/m
3
), n is the total number nanoneedles on a patch, r is 
the length of spinning arm, ω is the spinning speed, g’ is the relative centrifugal force (RCF, 300 
rpm = 12.8g), measured in multiples of earth gravity acceleration. After inputting all parameters 
with standard units, we got F = 2.2 nN at a centrifugal speed of 300 rpm.  
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